Cervical Cancer Prevention Sin Hang Lee, Jessica S. Vigliotti, Veronica S. Vigliotti and William Jones Abstract: The newly gained knowledge of the viral etiology in cervical carcinogenesis has prompted industrial interests in developing virology-based tools for cervical cancer prevention. Due to the long incubation period from viral infection to developing an invasive cancer, a process whose […]
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe HPV Genotypes: Nyasha Chin’ombe1*, Natasha L Sebata1, Vurayai Ruhanya1 and Hilda T Matarira2 Abstract Cervical cancer is one of the major causes of morbidity and mortality in women in Zimbabwe. This is mainly due to the high prevalence of high-risk human papillomavirus (HPV) genotypes in the population. So […]
HPV Vaccines: Have They Provided a Benefit for You?
Benefit? [SaneVax: The FDA/CDC and government health officials around the globe are brushing off adverse events experienced after HPV vaccinations as ‘coincidence’ despite the fact that these ‘coincidences’ are occurring at more than twice the rate of other vaccines. In direct response to government’s lack of concern independent research scientist, Dr. Chandler Marrs has taken up […]
Influenza: marketing vaccine by marketing disease
Influenza Influenza… by Peter Doshi, Postdoctoral Fellow: BMJ 2013;346:f3037 The CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so. Promotion of flu vaccines is one of the most visible and aggressive public […]
Vaccines and Medications: Undue Pharmaceutical Manufacturers’ Influence
Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. Stamatakis E, Weiler R, Ioannidis JP. Source Department of Epidemiology and Public Health, University College London, London, UK; Prevention Research Collaboration, School of Public Health, University of Sydney, Sydney, NSW, Australia. Abstract BACKGROUND: Expenditure on industry products (mostly drugs and devices) has spiraled over […]